USA Change Macroaxis User Registration

Home Portfolios Solutions About Us

More ROI Blog

Company Contact UsPress ReleasesTerms Of UseAdvertisingWays To Invest

US Market Open: Feb 9, 16:09 PM 2012

NYSE 8081.50 1.48 Index Moved Down

NASDAQ 2927.23 11.37 Index Moved Up

and more..

sponsered by

Processing
Collecting necessary data for MSFT and MRK...

Asset Comparison and Correlation

View All Portfolios

More Actions
- Select Assests
- Optimize Portfolio
- Suggest Portfolio
- Backtest Watchlist
- Analyze Correlations
- View Transactions
- Check Volatilities
- Import Equities
- Search Equities
- Filter Tops

Microsoft Corp. and

Merck & Company Inc. Comm

Volatility

Matrix

Run Correlation

Diversification

Significant diversification

Overlapping area represents amount of risk that can be diversified away by holding Microsoft Corp. and Merck & Company Inc. Comm in the same portfolio (assuming nothing else is changed)

Optimize

Correlation Coefficient

0.07

Parameters

Time Period	1 Month [change]
Direction	Positive
Strength	Insignificant
Accuracy	100.0%
Values	Daily Returns

Suggest

Microsoft Corporation

Profile

30.74

Intraday

One Month

^0.08

0.24%

MSFT

NASDAQ

Microsoft Corporation

P/E	11.11	Day Low	30.48
Open	30.64	P/B Ratio	4.01
Market Cap	257.9B	Volume	42920112
Sector	Technology	Last Close	30.66
Short Ratio	1.90	Last Traded	2/9/2012
Year High	30.67	Percent Change	0.24%
EBITDA	29.992B	Year Low	23.65
Absolute Change	0.08	Time	Not Applicable
Book Value	7.65	EPS	2.759
PEG Ratio	1.35	Employees	90,000
Day High	30.80	Industry	Application Software
Target Price	31.65	Current EPS	2.759
This Year EPS	2.68	Next Year EPS	2.99
Current PE	11.11	This Year PE	11.44
Next Year PE	10.25	Dividend	0.68
Dividend Yield	2.22	Dividend Date	Mar 8

Merck & Company Inc. Common St

Profile

38.15

Intraday

One Month

^(0.27)

0.70%

MRK

NYSE

Merck & Company Inc. Comm

P/E	19.00	Day Low	38.14
Open	38.39	P/B Ratio	2.13
Market Cap	116.3B	Volume	7597382
Sector	Healthcare	Last Close	38.42
Short Ratio	2.10	Last Traded	2/9/2012
Year High	39.43	Percent Change	0.70%
EBITDA	17.398B	Year Low	29.47
Absolute Change	0.27	Time	Not Applicable
Book Value	18.067	EPS	2.022
PEG Ratio	2.78	Employees	86,000
Day High	38.52	Industry	Drug Manufacturers -
Target Price	40.79	Current EPS	2.022
This Year EPS	3.81	Next Year EPS	3.72
Current PE	19.00	This Year PE	10.08
Next Year PE	10.33	Dividend	1.56
Dividend Yield	4.06	Dividend Date	Jan 9